PIQ Stock Overview
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Proteomics International Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.14 |
| 52 Week High | AU$1.35 |
| 52 Week Low | AU$0.71 |
| Beta | 0.90 |
| 1 Month Change | 4.11% |
| 3 Month Change | 23.91% |
| 1 Year Change | 2.70% |
| 3 Year Change | 307.14% |
| 5 Year Change | 307.14% |
| Change since IPO | 406.67% |
Recent News & Updates
Recent updates
Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being
Nov 17
Is Proteomics International Laboratories (ASX:PIQ) In A Good Position To Invest In Growth?
Aug 09We Think Proteomics International Laboratories (ASX:PIQ) Can Afford To Drive Business Growth
Oct 20We're Not Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn
May 31Why Proteomics International Laboratories' (ASX:PIQ) CEO Pay Matters
Feb 12
We're Hopeful That Proteomics International Laboratories (ASX:PIQ) Will Use Its Cash Wisely
Jan 08Is Proteomics International Laboratories' (ASX:PIQ) 172% Share Price Increase Well Justified?
Dec 04Shareholder Returns
| PIQ | AU Life Sciences | AU Market | |
|---|---|---|---|
| 7D | 4.1% | 2.0% | 0.4% |
| 1Y | 2.7% | -52.3% | 0.4% |
Return vs Industry: PIQ exceeded the Australian Life Sciences industry which returned -49.9% over the past year.
Return vs Market: PIQ matched the Australian Market which returned 1.8% over the past year.
Price Volatility
| PIQ volatility | |
|---|---|
| PIQ Average Weekly Movement | 6.7% |
| Life Sciences Industry Average Movement | 8.7% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in AU Market | 15.5% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: PIQ is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: PIQ's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Richard Lipscombe | https://www.proteomics.com.au |
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research.
Proteomics International Laboratories Limited Fundamentals Summary
| PIQ fundamental statistics | |
|---|---|
| Market Cap | AU$134.82m |
| Earnings (TTM) | -AU$4.97m |
| Revenue (TTM) | AU$3.43m |
39.3x
P/S Ratio-27.1x
P/E RatioIs PIQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PIQ income statement (TTM) | |
|---|---|
| Revenue | AU$3.43m |
| Cost of Revenue | AU$2.06m |
| Gross Profit | AU$1.37m |
| Other Expenses | AU$6.35m |
| Earnings | -AU$4.97m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.042 |
| Gross Margin | 40.01% |
| Net Profit Margin | -144.98% |
| Debt/Equity Ratio | 0% |
How did PIQ perform over the long term?
See historical performance and comparison